Search results
Prior to joining Oncolytics, Dr. Thomas Heineman was Senior Vice President and Head of Clinical Development at Denovo Biopharma. Prior to his time at Denovo, he served as Vice President and Head of Clinical Development at both Genocea Biosciences and Halozyme Therapeutics.
Sep 15, 2016 · View Thomas Heineman’s profile on LinkedIn, a professional community of 1 billion members. A recognized leader in the biopharmaceutical industry with a record of accomplishment in…
- 500+
- Oncolytics Biotech Inc.
- 1.7K
Dec 21, 2021 · Dr. Heineman has co-authored over 60 peer-reviewed publications and is board certified in Internal Medicine and Infectious Diseases. He completed his fellowship in Infectious Diseases at the National Institutes of Health and his internship and residency at the University of Maryland.
View the profiles of people named Alex Heineman. Join Facebook to connect with Alex Heineman and others you may know. Facebook gives people the power to...
Dr. Heineman holds MD and PhD (Virology) degrees from the University of Chicago and has extensive experience in vaccine and drug development. Prior to joining Oncolytics as Chief Medical Officer, he held senior positions in biopharmaceutical companies dedicated to developing cancer therapeutics.
Nov 12, 2020 · On May 5, 2017, 15-year-old Sierrah Parmeter accused 16-year-old Alex Heineman of sexually assaulting her in the woods near a YMCA building that was hosting a gathering for teenagers in Hudson, Wisconsin.
During his stroke workup at Northwestern Memorial Hospital, Alex McKeown was found to have an aortic root aneurysm and a bicuspid aortic valve (BAV), which affects about 1% of the population. "You lose about 1.9 million brain cells per minute with a stroke."
